YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer

MT Newswires Live
2025/11/26

Shenzhen YHLO Biotech (SHA:688575) obtained medical device registrations from Guangdong's regulator for its sST2 chemiluminescence assay kit and the iMegaFlow chemiluminescence immunoassay analyzer.

The sST2 kit supports the diagnosis of acute myocardial infarction and heart failure, while the iMegaFlow analyzer enables the detection of analytes, according to a Wednesday filing with the Shanghai bourse.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10